Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

315
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
315
Seizures: Classification01:13

Seizures: Classification

632
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
632
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

1.0K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

LARON SYNDROME. (Growth Hormone Insensitivity) Geographical distribution and relationship to the genetic defects in the growth hormone receptor gene.

The Journal of clinical endocrinology and metabolism·2026
Same author

Early Neurological Complications Following Pediatric Liver Transplantation.

Pediatric transplantation·2026
Same author

Cefazolin for Methicillin-Susceptible <i>Staphylococcus aureus</i> Bacteremia.

The New England journal of medicine·2026
Same author

PET/CT as a Diagnostic Tool in Pediatric Fever of Unknown Origin: A Multicenter Study.

Pediatrics·2026
Same author

Prevalence, characteristics and outcomes of respiratory viral co-infection among hospitalized children.

European journal of pediatrics·2026
Same author

Adjunctive cenobamate in children and adolescents - real-world data from a retrospective multicenter study.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2026

Related Experiment Video

Updated: Sep 28, 2025

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients
09:32

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients

Published on: December 18, 2016

12.6K

Focal Epilepsy in Individuals with Laron Syndrome.

Lotem Goldberg1,2, Zvi Laron3,4, Liora Kornreich3,5

  • 1Department of Pediatrics B, Schneider Children's Medical Center of Israel, Petah Tiqva, Israel, lotem.yahav@gmail.com.

Hormone Research in Paediatrics
|March 31, 2022
PubMed
Summary

This study reveals that individuals with Laron syndrome (LS) may develop focal epilepsy, independent of childhood hypoglycemia. Effective seizure control was achieved in most patients with antiseizure medications.

Keywords:
EpilepsyInsulin-like growth factor-1Laron syndromeSeizures

More Related Videos

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
09:57

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

2.9K
Using a Bipolar Electrode to Create a Temporal Lobe Epilepsy Mouse Model by Electrical Kindling of the Amygdala
09:49

Using a Bipolar Electrode to Create a Temporal Lobe Epilepsy Mouse Model by Electrical Kindling of the Amygdala

Published on: June 29, 2022

2.7K

Related Experiment Videos

Last Updated: Sep 28, 2025

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients
09:32

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients

Published on: December 18, 2016

12.6K
Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
09:57

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

2.9K
Using a Bipolar Electrode to Create a Temporal Lobe Epilepsy Mouse Model by Electrical Kindling of the Amygdala
09:49

Using a Bipolar Electrode to Create a Temporal Lobe Epilepsy Mouse Model by Electrical Kindling of the Amygdala

Published on: June 29, 2022

2.7K

Area of Science:

  • Endocrinology
  • Neurology
  • Genetics

Background:

  • Laron syndrome (LS) is a rare genetic disorder characterized by insulin-like growth factor 1 (IGF-1) deficiency.
  • Focal epilepsy is a neurological condition involving abnormal electrical activity in specific brain regions.

Discussion:

  • This study highlights a potential association between Laron syndrome and the development of focal epilepsy.
  • The observed epilepsy in LS patients appears distinct from seizures potentially related to hypoglycemia.
  • Electroencephalogram findings indicated temporal lobe involvement in the epilepsy associated with LS.

Key Insights:

  • Four cases of concomitant focal epilepsy and Laron syndrome are described for the first time.
  • Two patients experienced status epilepticus, a severe form of epilepsy.
  • Three out of four patients achieved long-term seizure freedom with antiseizure medications.

Outlook:

  • Further research is warranted to elucidate the underlying mechanisms connecting Laron syndrome and focal epilepsy.
  • Investigating genetic or molecular pathways may reveal novel therapeutic targets.
  • Long-term monitoring of patients with Laron syndrome for neurological complications is recommended.